Study of programmed cell death in bovine herpesvirus 1 infected mdbk cells and the possible role of nitric oxide in this process

Bovine herpesvirus 1 (BHV-1) is the aetiological agent of many disease types and may predispose infected animals, possibly through immunosuppression, to secondary bacterial infections. Immunosuppression may directly be associated with the induction of programmed cell death (PCD) in some virus-infect...

Full description

Saved in:
Bibliographic Details
Published inActa veterinaria Hungarica (Budapest. 1983) Vol. 52; no. 3; pp. 287 - 297
Main Authors Yazici, Z, Baskin, Yasemin, Baskin, H, Gecer, Ozlem, Bahar, I H, Ozkul, A
Format Journal Article
LanguageEnglish
Published Hungary Akadémiai Kiadó 01.01.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bovine herpesvirus 1 (BHV-1) is the aetiological agent of many disease types and may predispose infected animals, possibly through immunosuppression, to secondary bacterial infections. Immunosuppression may directly be associated with the induction of programmed cell death (PCD) in some virus-infected cells. Nitric oxide (NO) has an important mediating role against fungal, bacterial, protozoal, viral pathogens and tumours. BHV-1 induced apoptosis between 0.5-3 h postinfection (PI) in MDBK cells; however, between 3 and 6 h PI the PCD response was found to be decreased. It was interesting to see that BHV-1 inhibited staurosporin-induced PCD after 1 h. These results showed similarities with those obtained from herpes simplex type 1 infections in human epithelial cells. PCD response decreased 1 h following caspase-3 inhibitor applications, whereas NO response increased 3 h following infection in the presence of caspase-8 and -9 inhibitory peptides. In conclusion, BHV-1 inhibited the staurosporin-induced apoptotic response and also the NO response. We propose that this inhibition is caspase-3 dependent.
Bibliography:http://dx.doi.org/10.1556%2FAVet.52.2004.3.5
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0236-6290
1588-2705
DOI:10.1556/AVet.52.2004.3.5